FDA Inspection 963366 — Astellas Pharma Inc.
The FDA completed an inspection of Astellas Pharma Inc. on Mar 7, 2016 in Yaizu. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yaizu (Japan)